ATE438412T1 - Zusammensetzung und verfahren zur medizinischen bilddarstellung von körperhöhlen - Google Patents

Zusammensetzung und verfahren zur medizinischen bilddarstellung von körperhöhlen

Info

Publication number
ATE438412T1
ATE438412T1 AT05759802T AT05759802T ATE438412T1 AT E438412 T1 ATE438412 T1 AT E438412T1 AT 05759802 T AT05759802 T AT 05759802T AT 05759802 T AT05759802 T AT 05759802T AT E438412 T1 ATE438412 T1 AT E438412T1
Authority
AT
Austria
Prior art keywords
composition
image
body cavity
cavies
medical imaging
Prior art date
Application number
AT05759802T
Other languages
English (en)
Inventor
Mark Hans Emanuel
Niek Exalto
Original Assignee
Gynaecologiq B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34928373&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE438412(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gynaecologiq B V filed Critical Gynaecologiq B V
Application granted granted Critical
Publication of ATE438412T1 publication Critical patent/ATE438412T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasonic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasonic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/226—Solutes, emulsions, suspensions, dispersions, semi-solid forms, e.g. hydrogels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasonic imaging preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acoustics & Sound (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
AT05759802T 2004-07-15 2005-07-14 Zusammensetzung und verfahren zur medizinischen bilddarstellung von körperhöhlen ATE438412T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04077057 2004-07-15
PCT/NL2005/000507 WO2006006861A1 (en) 2004-07-15 2005-07-14 Composition and method for medical imaging of body cavities

Publications (1)

Publication Number Publication Date
ATE438412T1 true ATE438412T1 (de) 2009-08-15

Family

ID=34928373

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05759802T ATE438412T1 (de) 2004-07-15 2005-07-14 Zusammensetzung und verfahren zur medizinischen bilddarstellung von körperhöhlen

Country Status (6)

Country Link
US (2) US8992887B2 (de)
EP (1) EP1793860B1 (de)
AT (1) ATE438412T1 (de)
DE (1) DE602005015872D1 (de)
ES (1) ES2331195T3 (de)
WO (1) WO2006006861A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1793860B1 (de) 2004-07-15 2009-08-05 GynaecologIQ B.V. Zusammensetzung und verfahren zur medizinischen bilddarstellung von körperhöhlen
WO2009137446A2 (en) * 2008-05-05 2009-11-12 Pluromed, Inc. Methods of preventing fluid leaks from body cavities during medical imaging procedures
US20100087798A1 (en) * 2008-09-24 2010-04-08 Interlace Medical, Inc. Systems, methods and devices for using a flowable medium for distending a hollow organ
NL2003660C2 (en) 2009-10-16 2011-04-19 Giskit B V Composition and method for medical imaging of body cavities.
DE102009054956A1 (de) 2009-12-18 2011-06-22 Siemens Aktiengesellschaft, 80333 Magnetresonanztomographie-Bildgebung
JP5881698B2 (ja) * 2010-07-19 2016-03-09 ブラセルズ ベンチャーズ コーポレーションＢｒｕｓｅｌｌｓ Ｖｅｎｔｕｒｅｓ Ｃｏｒｐ． エーテルヒドロキシエチルセルロースを含む抗微生物医療用ジェル
NL2019159B1 (en) 2017-06-30 2019-01-14 Giskit B V Echogenic image enhancing compositions, preparation and use thereof.
WO2026037914A1 (en) 2024-08-14 2026-02-19 Richter Gedeon Nyrt. Composition and method for improving medical imaging of fallopian tubes, preparation and uses thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681119A (en) * 1980-11-17 1987-07-21 Schering Aktiengesellschaft Method of production and use of microbubble precursors
US4680175A (en) * 1984-02-07 1987-07-14 Interferon Sciences, Inc. Interferon administration vehicles
DE3577185D1 (de) * 1984-11-01 1990-05-23 Nycomed As Paramagnetische kontrastmittel fuer die anwendung in "in vivo" nmr-diagnostischen methoden und die herstellung davon.
US5425366A (en) 1988-02-05 1995-06-20 Schering Aktiengesellschaft Ultrasonic contrast agents for color Doppler imaging
US5188826A (en) 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5352434A (en) * 1992-05-01 1994-10-04 Sterling Winthrop Inc. X-ray contrast compositions containing a barium salt and film-forming materials
EP0669823A4 (de) 1992-10-06 1996-03-13 Molecular Biosystems Inc Ultraschallbilderzeugung von Körperhöhle.
WO2004073750A1 (en) 1995-06-07 2004-09-02 Harald Dugstad Improvements in or relating to contrast agents
US20030206862A1 (en) 1998-02-07 2003-11-06 Thomas Gieselmann Contrast medium based on polyoxyethylene-660-12-hydroxystearate and anionic phospholipids
US20050255039A1 (en) 1998-06-26 2005-11-17 Pro Surg, Inc., A California Corporation Gel injection treatment of breast, fibroids & endometrial ablation
US6231513B1 (en) 1998-10-14 2001-05-15 Daum Gmbh Contrast agent for ultrasonic imaging
US6280702B1 (en) * 1999-04-30 2001-08-28 Chek-Med Systems, Inc. Endoscopy tissue stain
WO2001024775A1 (en) 1999-10-01 2001-04-12 Essentia Biosystems, Inc. Gel-forming compositions
US20020010150A1 (en) 2000-04-28 2002-01-24 Cortese Stephanie M. Homostatic compositions of polyacids and polyalkylene oxides and methods for their use
ZA200404023B (en) 2001-11-21 2005-05-24 E Z Em Inc Formulations for use in medical or diagnostic procedures.
PL374188A1 (en) * 2002-05-09 2005-10-03 Ultrast Llc Medium for contrast enhancement use for ultrasonic, endoscopic and other medical examinations
US20080206161A1 (en) 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
EP1793860B1 (de) 2004-07-15 2009-08-05 GynaecologIQ B.V. Zusammensetzung und verfahren zur medizinischen bilddarstellung von körperhöhlen
WO2007030002A1 (en) 2005-09-07 2007-03-15 Gynaecologiq B.V. Sealing stopper and assembly comprising such a sealing stopper
JP4450788B2 (ja) 2005-11-30 2010-04-14 株式会社日立ハイテクインスツルメンツ 電子部品装着装置

Also Published As

Publication number Publication date
DE602005015872D1 (de) 2009-09-17
EP1793860B1 (de) 2009-08-05
US20150182639A1 (en) 2015-07-02
ES2331195T3 (es) 2009-12-23
US9717805B2 (en) 2017-08-01
EP1793860A1 (de) 2007-06-13
WO2006006861A1 (en) 2006-01-19
US8992887B2 (en) 2015-03-31
US20080286206A1 (en) 2008-11-20

Similar Documents

Publication Publication Date Title
DOP2009000269A (es) Anticuerpos humanizados contra el globulomero ab(20-42) y sus usos
MX2007001035A (es) Metodo para producir una composicion, la composicion y su uso.
TW200714283A (en) Method and composition for treating peripheral vascular diseases
DE602004031134D1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
ATE482966T1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
BRPI0519285A2 (pt) biomaterial implatável e método de produzir o mesmo
DE602004024572D1 (de) Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen
ATE540950T1 (de) Aminocyclohexane als dipeptidylpeptidase-iv- hemmer zur behandlung bzw. prävention von diabetes
EA200602077A1 (ru) Активируемые частицы, их получение и применение
SG155947A1 (en) Compositions and methods for the diagnosis and treatment of tumor
CL2007000789A1 (es) Compuestos derivados de malonamida, inhibidores de la gamma-secretasa; proceso de preparacion; composicion farmaceutica; y su uso en el tratamiento de la enfermedad de alzheimer.
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
ATE435209T1 (de) Verfahren zur herstellung von montelukast-natrium
ATE544566T1 (de) Verfahren zur herstellung von dünne metallnanodrähte durch biotemplating
ATE453328T1 (de) Verbesserte formulierung zur bereitstellung eines magensaftresitenten beschichtungsmaterials
ATE547009T1 (de) Zusammensetzungen und verfahren zur förderung von körperfettverlust
ATE438412T1 (de) Zusammensetzung und verfahren zur medizinischen bilddarstellung von körperhöhlen
CY1113871T1 (el) Διαδικασια παρασκευης γκαμπαπεντινης
EA200701648A1 (ru) Замещённые пирролы и имидазолы, содержащие их композиции, способ получения и применение
ATE555019T1 (de) Verfahren zur erzeugung flüssiger zubereitungen mit festkörpergehalt
CY1110156T1 (el) Υποκατεστημενες ενωσεις 4,5,6,7-τετραϋδρο-βενζοθειαζολ-2-υλαμινης
EA200701826A1 (ru) Способ и композиция для лечения диабета
FR2873037B1 (fr) Methodes et compositions pour le traitement de cancers
ATE487730T1 (de) Verfahren zur herstellung eines oxaliplatins
ATE503476T1 (de) Zusammensetzungen und verfahren zur behandlung von krankheiten, die durch infektion mit yersinia spp ausgelöst sind

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties